phrykt

Myomo, Inc. (MYO): who owns it and who trades it

As of Nov 16, 2026, MYO insiders reported 8 open-market sales worth $231K and 13 purchases worth $443K in the last 12 months, with 0% of the sale value made under pre-set 10b5-1 plans. The largest seller was Harry Kovelman (Chief Medical Officer), with $132K. 3 of the 50 famous funds we follow held it at their last quarter end.

Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Who is buying and selling Myomo

From the latest filings

Overall: more buying than selling. Insiders and famous investors mostly bought.

Mostly sellingEvenMostly buying

Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.

Who owns MYO

80 funds and institutions reported MYO shares worth $12.7M at the end of Q2 2026, about 32% of the company. The largest holder is Rosalind Advisors, Inc. with 9.4%.

Funds and institutions (13F) 32%Everyone else 68%

10 largest owners, by share of the company

Rosalind Advisors, Inc.9.4%
Vanguard Capital Management LLC4.2%
AQR Capital Management LLC2.4%
Jefferies Financial Group Inc.1.8%
Jane Street Group, LLC1.5%
Clearstead Advisors, LLC1.1%
UBS Group AG1.1%
Geode Capital Management, LLC0.9%
LPL Financial LLC0.8%
Palumbo Wealth Management LLC0.8%

Top 20 owners

OwnerShares% of companyValueChange since Q1 2026
Rosalind Advisors, Inc.3.64M9.45%$3.8M–
Vanguard Capital Management LLC1.64M4.25%$1.7M–
AQR Capital Management LLC928,2682.41%$965K–
Jefferies Financial Group Inc.704,2751.83%$732K–
Jane Street Group, LLC596,3521.55%$620K–
Clearstead Advisors, LLC425,6091.11%$443K–
UBS Group AG413,6791.07%$430K–
Geode Capital Management, LLC344,4170.89%$358K–
LPL Financial LLC308,0000.80%$320K–
Palumbo Wealth Management LLC299,7760.78%$312K–
Gsa Capital Partners LLP271,8760.71%$283K–
Millennium Management LLC271,2940.70%$282K–
BlackRock, Inc.223,2170.58%$232K–
Vanguard Fiduciary Trust Co207,6770.54%$216K–
BNP Paribas Financial Markets139,1940.36%$145K–
Ieq Capital, LLC127,7490.33%$133K–
Susquehanna International Group, LLP120,7910.31%$126K–
XTX Topco Ltd110,0280.29%$114K–
State Street Corp105,8750.27%$110K–
Citadel Advisors LLC102,5180.27%$107K–

From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.

Insider trades

In the last 12 months, MYO insiders reported $443K of open-market purchases and $231K of sales. 0% of the sale value was under a 10b5-1 plan, a schedule set up in advance.

Purchases, 12 months
$443K
13 trades, 4 people
Sales, 12 months
$231K
8 trades, 3 people
Sales under a 10b5-1 plan
0%
Share of sale value
Latest trade
Sep 11, 2026
Filed Oct 15, 2026

Purchases and sales by month

$267K$267KDecFebAprJunAugOct
Purchases Sales Click a bar to show only that month below

Latest trades

DateInsiderRoleTypeSharesPriceValueFiling
Sep 11, 2026Harry KovelmanChief Medical OfficerSale15,844$1.27$20.1KForm 4
Sep 11, 2026Harry KovelmanChief Medical OfficerSale15,488$1.27$19.7KForm 4
Sep 2, 2026Milton Mayo MorrisDirectorSale15,000$1.41$21.1KForm 4
Aug 20, 2026Harry KovelmanChief Medical OfficerSale17,500$1.73$30.3KForm 4
Aug 20, 2026Harry KovelmanChief Medical OfficerSale17,250$1.73$29.8KForm 4
Jun 5, 2026Thomas F KirkDirectorPurchase40,002$1.27$50.8KForm 4
May 28, 2026Thomas F KirkDirectorPurchase25,000$0.99$24.8KForm 4
May 28, 2026Harry KovelmanChief Medical OfficerSale11,536$1.02$11.8KForm 4
May 27, 2026Harry KovelmanChief Medical OfficerSale20,464$1.00$20.5KForm 4
May 18, 2026Thomas F KirkDirectorPurchase43,401$0.91$39.5KForm 4
May 15, 2026Thomas F KirkDirectorPurchase31,605$0.91$28.8KForm 4
May 15, 2026Joseph M. Manko Jr.DirectorPurchase30,367$0.89$27KForm 4
May 14, 2026Micah MitchellChief Commercial OfficerSale90,231$0.86$77.6KForm 4
May 14, 2026Joseph M. Manko Jr.DirectorPurchase170,830$0.86$147KForm 4
Mar 16, 2026Heather C GetzDirectorPurchase20,000$0.70$14KForm 4
Mar 13, 2026Thomas F KirkDirectorPurchase72,000$0.71$51.1KForm 4
Mar 12, 2026Heather C GetzDirectorPurchase70,000$0.73$51.1KForm 4
Nov 21, 2025Thomas F KirkDirectorPurchase2,535$0.72$1.8KForm 4
Nov 20, 2025Thomas F KirkDirectorPurchase4,902$0.72$3.5KForm 4
Nov 19, 2025Thomas Aloysius Crowley Jr.DirectorPurchase385$0.77$296Form 4
Nov 18, 2025Thomas Aloysius Crowley Jr.DirectorPurchase4,000$0.73$2.9KForm 4

Insiders by value traded

InsiderRoleBoughtSoldLast trade
Thomas F KirkDirector$200K–Jun 5, 2026
Joseph M. Manko Jr.Director$174K–May 15, 2026
Harry KovelmanChief Medical Officer–$132KSep 11, 2026
Micah MitchellChief Commercial Officer–$77.6KMay 14, 2026
Heather C GetzDirector$65.1K–Mar 16, 2026
Milton Mayo MorrisDirector–$21.1KSep 2, 2026
Thomas Aloysius Crowley Jr.Director$3.2K–Nov 19, 2025
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

MYO short interest

Low short interest. 2.9% of MYO shares are sold short: about 1 share in 34. Over the last 12 reports the number of shares short went down 70%.

As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.

0%5%10%15%20%+

As of Oct 30, 2026, 1.16M MYO shares were sold short, 2.9% of the shares outstanding, up 8.6% from the report before. At the average daily volume of 201,201 shares, buying them all back would take about 5.8 trading days (days to cover).

Shares short, % of all shares

2.92%May 15Oct 3011.0%

Days to cover

5.8May 15Oct 3010.3

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 20261.16M2.92%+9%201,2015.8
Oct 15, 20261.06M2.69%-0%276,1263.9
Sep 30, 20261.07M2.69%-11%406,8282.6
Sep 15, 20261.20M3.02%+0%335,2573.6
Aug 31, 20261.19M3.01%+6%742,8561.6
Aug 14, 20261.12M2.84%-39%889,5671.3
Jul 31, 20261.85M4.66%-23%329,0765.6
Jul 15, 20262.41M6.26%-1%349,2286.9
Jun 30, 20262.44M6.33%-26%1.47M1.7
Jun 15, 20263.32M8.61%-4%1.53M2.2
May 29, 20263.44M8.94%-10%643,4235.3
May 15, 20263.81M9.90%-1%416,4979.2

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

Myomo company events

Myomo filed 9 reports on Form 8-K in the last 12 months, 5 of them about an important change (leadership). The latest was on Nov 9, 2026.

  1. Nov 9, 2026ResultsReleased financial results. Filing
  2. Aug 5, 2026ResultsReleased financial results. Filing
  3. Jun 29, 2026LeadershipAmended an earlier report. Amendment No. 3 to the Company's 2018 Stock Option and Incentive Plan, which was inadvertently labeled as Exhibit 3.1, (ii) to file under Item 5.03 an amendment to the Company's Eighth Amended and Restated Certificate of Incorporation, as amended, which was inadvertently labeled as Exhibit 10.1… Filing
  4. Jun 26, 2026LeadershipDeparture of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers; Compensatory Arrangements of Certain Officers. Filing
  5. May 13, 2026LeadershipUpon recommendation of the Nominating and Corporate Governance Committee of the Board of Directors of Myomo, Inc., the Board appointed Joseph M. Manko Jr. to join the Board, effective on May 9, 2026. Filing
  6. May 7, 2026ResultsReleased financial results. Filing
  7. Apr 16, 2026LeadershipUpon recommendation of the Nominating and Corporate Governance Committee of the Board of Directors of Myomo, Inc., the Board appointed William J. Febbo to join the Board, effective on April 14, 2026. Filing
  8. Mar 9, 2026ResultsReleased financial results. Filing
  9. Dec 16, 2025LeadershipThe Compensation Committee of the Board of Directors of Myomo, Inc. approved a salary-for-restricted stock units program open to all salaried employees pursuant to which (i) Paul Gudonis, the Company’s Chief Executive Officer, voluntarily elected to reduce his base salary for 2026 by 10% in… Filing

From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week

Myomo financials

Famous investors that hold MYO

3 of the 50 well-known investors we track reported holding MYO in their latest 13F filing. The largest position is Israel Englander's, worth $386K.

Position size

All holders

FundQuarterSharesValueOf portfolioChange
Israel Englander · Millennium ManagementQ3 2026247,380$386K0.0%-9%
Ken Griffin · Citadel AdvisorsQ3 2026109,786$171K0.0%+7%
Jim Simons · Renaissance TechnologiesQ3 2026101,700$159K0.0%+110%

From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.

5%+ stakes filed in the last 120 days

Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 2 filings named MYO in the last 120 days.

FiledHolderFormStake
Nov 12, 2026Rosalind Advisors, Inc.13G/A9.9%
Nov 12, 2026Rosalind Advisors, Inc.13G/A9.9%

Questions about Myomo, Inc. (MYO) stock

Who owns the most MYO stock?

The largest reported owner of Myomo, Inc. (MYO) is Rosalind Advisors, Inc., with 9.4% of the company. In total, 80 funds and institutions reported holding MYO at the end of Q2 2026, together about 32% of the shares. See the largest owners.

Are MYO insiders buying or selling?

In the last 12 months, MYO insiders reported 13 open-market purchases worth $443K and 8 sales worth $231K. The latest trade was on Sep 11, 2026. See every trade.

What is the short interest in MYO?

As of Oct 30, 2026, 1.16M MYO shares were sold short, 2.9% of the shares outstanding, up 8.6% from the report before. At the average daily volume of 201,201 shares, buying them all back would take about 5.8 trading days (days to cover). See the history.

Which famous investors hold MYO?

3 of the 50 well-known investors we track reported MYO in their latest 13F filing, including Israel Englander, Ken Griffin, Jim Simons. The largest position is worth $386K. See all holders.

Executive pay

Myomo's chief executive was paid a total of $1.2M for the year ended Dec 31, 2025, down 3% from $1.2M the year before. In the last 12 months, Myomo's executives and directors bought $443K of stock on the open market and sold $309K.

Chief executive, total pay$1.2MYear ended Dec 31, 2025. Salary, bonus and the value of stock and option awards when granted.
Other top executives, average$649KThe other officers named in the proxy statement.

From the pay versus performance table in the company's annual proxy statement (DEF 14A), as the company reported it. If the chief executive changed during the year, the company reports each person separately and this shows one of them.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.